Skip to main content
PMC home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1998;7(2):79–84. doi: 10.1080/09629359891216

Release of prostaglandin D2 by murine mast cells: importance of metabolite formation for antiproliferative activity.

C Haberl 1, L Hültner 1, A Flügel 1, M Falk 1, S Geuenich 1, W Wilmanns 1, C Denzlinger 1
PMCID: PMC1781833  PMID: 9836493

Abstract

Prostaglandin (PG) D2, PGJ2 and delta12-PGJ2 are antiproliferative eicosanoids. We investigated the production of PGD2 by murine bone marrow-derived mast cells (BMMC) taking into consideration metabolism of PGD2 to PGD2 and delta12-PGJ2. PG-metabolites were quantified by high performance liquid chromatography (HPLC) combined with radioimmunoassay (RIA). Stimulated with calcium ionophore A23187 BMMC released eight-fold more PGJ2 and delta12-PGJ2 than PGD2. Conversion of endogenously produced PGD2 to PGJ2 and delta12-PGJ2 proceeded rapidly in contrast to metabolism of exogenously added PGD2. The antiproliferative potency of these prostaglandins is demonstrated in vitro. We conclude that determination of PGD2 production by mast cells must take into consideration rapid conversion to active derivatives, which may play a significant role in growth regulation.

Full Text

The Full Text of this article is available as a PDF (222.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atsmon J., Freeman M. L., Meredith M. J., Sweetman B. J., Roberts L. J., 2nd Conjugation of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 with intracellular glutathione and enhancement of its antiproliferative activity by glutathione depletion. Cancer Res. 1990 Mar 15;50(6):1879–1885. [PubMed] [Google Scholar]
  2. Atsmon J., Sweetman B. J., Baertschi S. W., Harris T. M., Roberts L. J., 2nd Formation of thiol conjugates of 9-deoxy-delta 9,delta 12(E)-prostaglandin D2 and delta 12(E)-prostaglandin D2. Biochemistry. 1990 Apr 17;29(15):3760–3765. doi: 10.1021/bi00467a023. [DOI] [PubMed] [Google Scholar]
  3. Calender A., Billaud M., Aubry J. P., Banchereau J., Vuillaume M., Lenoir G. M. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc Natl Acad Sci U S A. 1987 Nov;84(22):8060–8064. doi: 10.1073/pnas.84.22.8060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Collins S. J., Gallo R. C., Gallagher R. E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature. 1977 Nov 24;270(5635):347–349. doi: 10.1038/270347a0. [DOI] [PubMed] [Google Scholar]
  5. Denzlinger C., Haberl C., Wilmanns W. Cysteinyl leukotriene production in anaphylactic reactions. Int Arch Allergy Immunol. 1995 Oct;108(2):158–164. doi: 10.1159/000237133. [DOI] [PubMed] [Google Scholar]
  6. Epstein M. A., Achong B. G., Barr Y. M., Zajac B., Henle G., Henle W. Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji). J Natl Cancer Inst. 1966 Oct;37(4):547–559. [PubMed] [Google Scholar]
  7. Fukushima M. Prostaglandin J2--anti-tumour and anti-viral activities and the mechanisms involved. Eicosanoids. 1990;3(4):189–199. [PubMed] [Google Scholar]
  8. Hültner L., Moeller J., Dörmer P. Reproducible generation of autonomous malignant sublines from non-tumorogenic murine interleukin 3-dependent mast cell lines. Blut. 1986 Dec;53(6):451–455. doi: 10.1007/BF00320309. [DOI] [PubMed] [Google Scholar]
  9. Hültner L., Moeller J., Schmitt E., Jäger G., Reisbach G., Ring J., Dörmer P. Thiol-sensitive mast cell lines derived from mouse bone marrow respond to a mast cell growth-enhancing activity different from both IL-3 and IL-4. J Immunol. 1989 May 15;142(10):3440–3446. [PubMed] [Google Scholar]
  10. Kim H. S., Lee J. H., Kim I. K. Intracellular glutathione level modulates the induction of apoptosis by delta 12-prostaglandin J2. Prostaglandins. 1996 Jun;51(6):413–425. doi: 10.1016/0090-6980(96)00047-0. [DOI] [PubMed] [Google Scholar]
  11. Murakami M., Penrose J. F., Urade Y., Austen K. F., Arm J. P. Interleukin 4 suppresses c-kit ligand-induced expression of cytosolic phospholipase A2 and prostaglandin endoperoxide synthase 2 and their roles in separate pathways of eicosanoid synthesis in mouse bone marrow-derived mast cells. Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):6107–6111. doi: 10.1073/pnas.92.13.6107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Narumiya S., Fukushima M. delta 12-Prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition. Biochem Biophys Res Commun. 1985 Mar 29;127(3):739–745. doi: 10.1016/s0006-291x(85)80005-x. [DOI] [PubMed] [Google Scholar]
  13. Negishi M., Koizumi T., Ichikawa A. Biological actions of delta 12-prostaglandin J2. J Lipid Mediat Cell Signal. 1995 Oct;12(2-3):443–448. doi: 10.1016/0929-7855(95)00029-p. [DOI] [PubMed] [Google Scholar]
  14. Ralph P., Moore M. A., Nilsson K. Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines. J Exp Med. 1976 Jun 1;143(6):1528–1533. doi: 10.1084/jem.143.6.1528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Razin E., Mencia-Huerta J. M., Lewis R. A., Corey E. J., Austen K. F. Generation of leukotriene C4 from a subclass of mast cells differentiated in vitro from mouse bone marrow. Proc Natl Acad Sci U S A. 1982 Aug;79(15):4665–4667. doi: 10.1073/pnas.79.15.4665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sasaki H., Fukushima M. Prostaglandins in the treatment of cancer. Anticancer Drugs. 1994 Apr;5(2):131–138. doi: 10.1097/00001813-199404000-00002. [DOI] [PubMed] [Google Scholar]
  17. Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer. 1980 Aug;26(2):171–176. doi: 10.1002/ijc.2910260208. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES